Essential thrombocythemia
ICD-10 Code
D47.3
Essential thrombocythemia
Definition
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. (WHO, 2008)
Also known as essential thrombocytemia, essential thrombocythemia, essential thrombocytosis, primary thrombocythemia, primary thrombocytosis — per MONDO
Also identified as
- DOID 2224 per MONDO
- ICD10CM D47.3 per MONDO
- ICD9 238.71 per MONDO
- MESH D013920 per MONDO
- NCIT C3407 per MONDO
- Orphanet 3318 per MONDO
- SCTID 109994006 per MONDO
- UMLS C0040028 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Bone marrow | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Bone marrow | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Hydroxyurea | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Alfa-N3 | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Beta-1B | may treat | MEDRT · Public domain (U.S. Government work) |
| Interferon Gamma-1b | may treat | MEDRT · Public domain (U.S. Government work) |
| Peginterferon Alfa-2a | may treat | MEDRT · Public domain (U.S. Government work) |